pharma · Migraine · Narcolepsy
H. Lundbeck A/S
H. Lundbeck A/S is a pharma organization headquartered in Valby, CN. Primary therapeutic focus areas include Migraine, Narcolepsy, Schizophrenia, Multiple System Atrophy, Chronic Migrane, Migrane, Medication Overuse Head
Postboks 361, LYSAKER, Bærum 1326, NO, Valby, CN HQ
112 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Postboks 361, LYSAKER, Bærum 1326, NO, Valby, CN
- Employees
- 112
- Programs
- 17
- Drugs
- 14
- Patents
- 0
Lu AF28996
Phase 1 · small molecule · Parkinson Disease
Lu AF28996 for Parkinson Disease is a Phase 1 program (small_molecule) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).
Internal code 20501A
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- H. Lundbeck A/S
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Parkinson Disease
- Status
- active
- Trials
- 1